Company Overview - Tongling Jeya Biotechnology Co., Ltd. was established in 1999 and specializes in the research, production, and sales of wet wipes, accumulating over 20 years of industry experience [2]. - The company was listed on the Shenzhen Stock Exchange's Growth Enterprise Market on December 3, 2021 [2]. Financial Performance - For the first three quarters of 2025, the company reported a revenue of 5.65 billion CNY and a net profit of 6,790.31 million CNY [2]. Q&A Highlights Production and Expansion - The U.S. factory is currently in the equipment installation and debugging phase, expected to commence production in the second half of this year [2]. - Land has been purchased in Egypt for future expansion to cover global markets outside the U.S., with the project still in the early planning stages [3]. Mergers and Acquisitions - The company is actively seeking quality acquisition targets that can create synergies with existing operations and add substantial value for long-term growth [3]. Product Lines and Market Strategy - There are no significant planned investments in the collagen business at this time [3]. - The performance of personal care products is currently limited in order volume, but customer expansion efforts are ongoing [3]. - The company's core competitive advantages lie in its long-term focus on the wet wipes market, with strengths in technology R&D, production processes, quality control, customer resources, and product variety [3]. Future Growth Prospects - Future growth is expected to come from deepening collaborations with existing international brand clients and expanding product categories and sales regions, as well as leveraging new market opportunities and localized supply chain advantages from the U.S. factory [3]. Compliance and Governance - The company adhered to the Shenzhen Stock Exchange's regulations during the investor communication event, ensuring no significant undisclosed information was leaked [3].

Company Overview - Feilong Automotive Parts Co., Ltd. has over 70 years of development history, focusing on thermal management system solutions since its establishment in 1952 [1] - The company has two main development phases: prior to 2017, focusing on automotive thermal management components; from 2017 onwards, expanding into civilian market clients and rapid transformation [1][2] Product Development and Market Reach - The company has established four R&D centers in Shanghai, Wuhu, Nanyang, and Xixia, with a focus on developing electronic pumps and temperature control valves for new energy thermal management [2] - Products are sold nationwide and exported to over 200 domestic and international clients, serving more than 300 factory bases globally [2] Key Products and Innovations - The main products in the new energy thermal management sector include electronic pumps and temperature control valves, with plans to expand into integrated module solutions [5] - The electronic oil pump is primarily used in automotive engine oil systems, transmission oil systems, and steering assist systems [6] Performance and Growth Drivers - The company's turbine shell product won the national industrial champion title in 2024, significantly contributing to business growth and applicable in both traditional and new energy vehicles [3] - The company has implemented strategies to mitigate raw material price fluctuations, including centralized procurement and inventory management [4] Client Base and Market Strategy - Major clients for thermal management integrated modules include Chery, Nanjing Automotive, and Geely, with increasing sales volume and scale effects [7] - The company has established partnerships with over 40 leading enterprises in the server liquid cooling field, enhancing its market presence [7] Future Development Strategy - The company aims to solidify its automotive thermal management business while transitioning to a system solution provider [8] - Plans to expand overseas operations, particularly in Southeast Asia and Central Asia, leveraging its Thai production base [8] - The company is exploring new applications for thermal management technology in high-tech fields such as server liquid cooling, charging pile liquid cooling, and 5G base stations [8]

Group 1: Overview of Collaboration - HaiSiKe's PDE3/4 overseas authorization aims to achieve a win-win model by retaining Chinese rights while sharing overseas profits, accelerating the molecule's international deployment [2] - The company anticipates a period of international harvest and business development explosion in 2026, with ongoing expansion into oncology and large molecules [2] - The TYK2 project (FTP637) successfully entered overseas markets through a NEWCO model, completing phases 1-3 of clinical trials in about five years [3] Group 2: Key Collaboration Details - Transaction partner: AirNexis, led by Frazier Fund, with a transaction amount exceeding $1 billion, including an upfront payment of over $100 million and milestone payments of $955 million, along with double-digit sales sharing [3] - AirNexis is responsible for overseas clinical development and commercialization, while HaiSiKe retains rights for HSK39004 in China and global exclusive rights for combination formulations [3] - HaiSiKe's focus is on long-term benefits and overseas development efficiency while ensuring the protection of Chinese rights [4] Group 3: Clinical Progress and Differentiation - HaiSiKe is advancing both inhalation suspension and dry powder inhalation formulations, with the latter being globally leading [5] - The key phase 2 data in China is expected to be released in Q1 2026, with plans to initiate phase 3 studies for COPD in Q2 2026, aiming for NDA submission by late 2027 or Q1 2028 [5] - AirNexis plans to conduct population pharmacokinetics studies, with an NDA submission in the U.S. anticipated by Q4 2028 and potential approval by Q1 2030 [5] Group 4: Future Development and Opportunities - HaiSiKe is actively pursuing multiple projects in CNS and oncology, with hopes to initiate 1-2 key clinical trials in oncology by 2026 [7] - The company aims to independently conduct clinical research in the U.S. to generate proof-of-concept data before seeking external authorization partnerships, which could lead to larger transaction amounts [7] - Future collaborations may also involve platform-based R&D capabilities with leading multinational pharmaceutical companies or top-tier overseas investment funds [7] Group 5: Research and Development Focus - The R&D direction will focus on perioperative, respiratory, autoimmune, and oncology fields, expanding into biologics, ADCs, and cyclic peptides [8] - Short-term goals include advancing the approval of环泊酚 in the U.S., while mid-term goals involve achieving overseas market entries for DPP1 and PDE3/4 projects [8] - Long-term objectives include learning international market regulations and building a scalable overseas team [8]

证券代码： 300286 证券简称：安科瑞 编号：2026-001 安科瑞电气股份有限公司投资者关系活动记录表 5.产品研发迭代的核心方向是什么？ 答：研发迭代聚焦三大方向：一是 AI 与能源管理深度融合，持续优化 EMS 3.0 平台算法，提升负荷预测精度与能源调度效率，拓展数字孪生 + 区块链碳 追踪等创新功能，适配住建部碳足迹管理试点需求；二是绿色低碳产品创新，重 点开发适配分布式光伏、储能的防逆流保护装置、微电网能量管理控制系统等产 品，助力用户实现绿电消纳与节能降耗；三是行业定制化升级，针对轨道交通、 石化、数据中心等重点行业的特殊需求，优化产品的环境适应性与功能适配性， 同时推进硬件产品的小型化、智能化与无线化升级。 6.2025 年公司行业推广的核心目标与策略是什么？ | | ■特定对象调研 □分析师会议 □媒体采访 □业绩说明会 | | --- | --- | | 投资者关系活动 | | | 类别 | □新闻发布会 □路演活动 | | | ■现场参观 □一对一沟通 | | □其他 | （电话会议） | | 见附件 | | | 参与单位名称 | | | 时间 2026 | 年 1 月 8 日 | ...

Group 1: Company Overview - Anhui Honglu Steel Structure Group's production capacity reached 5.2 million tons in 2025, marking an 11.3% increase from the previous year [7] - The company has ten production bases, with approximately 3,000 welding robots deployed across these sites [2] Group 2: Technological Advancements - The company has actively pursued smart manufacturing, introducing advanced equipment such as high-power laser cutting machines and industrial welding robots [2] - The "Honglu Master Riveting Detection Robot" has been developed for full-process operations on six types of components, with limited deployment in production bases [2] Group 3: Financial Performance - In 2025, the company signed new sales contracts totaling approximately RMB 29.102 billion, a 2.84% increase year-on-year [7] - The pricing strategy for products is based on "material cost + processing fee," with a focus on enhancing product quality and service delivery [5] Group 4: Future Plans - The company is considering expanding its overseas business based on market demand, although current clients are primarily domestic [3] - Plans for 2026 include optimizing control over production processes to enhance core competitiveness [4] Group 5: Investor Relations - The company is committed to timely information disclosure regarding convertible bond adjustments and will consider various factors in decision-making [6] - Investors were shown the company's production operations through a video monitoring center during the investor relations activity [1]

Group 1: Impact of Raw Material Prices - Recent increases in copper and other metal prices have affected the company's raw material costs, but the company employs a cost-plus pricing model to adjust prices based on customer requirements and production factors [1] - The company is actively pursuing new materials and processes to meet customer demands while managing procurement based on order volume and price trends [1] Group 2: Market Position and Competition - The company's market share in the zipper business is relatively small due to a lack of comprehensive industry statistics [1] - The apparel accessories industry is characterized by low concentration and intense competition, particularly in the mid-to-low-end product segments, with increasing challenges for small and medium enterprises [2] - As consumer demand shifts towards mid-to-high-end brands, larger companies with strong competitive advantages are likely to benefit, leading to further industry consolidation [2] Group 3: Company Operations and Future Outlook - The company established a wholly-owned subsidiary, SAB AMERICA INC., in the U.S. in 2024 to better serve local customer needs, with normal operational status [3] - The company maintains a cautious outlook on short-term industry recovery due to current international trade conditions and consumer sentiment, but is optimistic about long-term growth in the apparel accessories sector [4] - Future capital expenditures will focus on smart manufacturing improvements and overseas capacity expansion, with a commitment to risk control [6] Group 4: Financial Guidance and Dividend Policy - Detailed performance guidance for 2026 will be provided in future announcements, with a focus on long-term development goals outlined in the company's sixth equity incentive plan [5] - The company adheres to a sustainable development philosophy, considering annual profits, future needs, and shareholder interests when formulating profit distribution plans [7]

投资者关系活动记录表 投资者关系活动 类别 √特定对象调研 □分析师会议 □媒体采访 □业绩说明会 □新闻发布会 □路演活动 □现场参观 □其他 参与单位名称及 人员姓名 西部证券 刘小龙 时间 2026 年 1 月 12 日 地点 公司会议室 上市公司接待人 员 董事会秘书董旭海、董事会办公室人员 投资者关系活动 主要内容介绍 投资者：氨纶情况？ 答：氨纶的底部基本确认了，行业中有经营困难和计划要退 出的企业，对市场的影响还得继续观察。 投资者：公司产品在航天的应用主要是芳纶纸吗？ 答：主要是芳纶纸。 投资者：主要用在哪方面？ 答：整流罩等方面。 投资者：在这一领域的价格怎样? 答：在芳纶蜂窝领域的价格要稍微贵一些，性能要求不同。 投资者：主要是供应哪里？ 答：供应芳纶蜂窝生产厂家。 投资者：氨纶的情况？ 答：2025 年同比有所减亏，2026 年这一趋势预计还会继续。 1 投资者关系活动记录表 证券代码：002254 证券简称：泰和新材 泰和新材集团股份有限公司 投资者关系活动记录表 编号：2026-009 | | 投资者：减亏的主要原因是什么？ | | --- | --- | | | 答：主要是公司内部 ...

Regulatory Changes - In 2025, the Ministry of Agriculture and Rural Affairs will continue to improve pesticide management regulations, focusing on more standardized, green, and high-quality development of the pesticide industry [3][4] - The "One Product, One Certificate" policy, effective from January 1, 2026, mandates that products with the same registration number must display the same trademark, enhancing product quality and market order [4] Market Landscape - The domestic plant growth regulator industry has over 500 companies, with approximately 1,900 registration certificates held, averaging 3.6 certificates per company [5] - The company holds 150 plant growth regulator registration certificates, accounting for 7.7% of the total, making it the leading enterprise in this sector [5] Product Strategy - The company promotes a comprehensive solution to provide one-stop services for customers, enhancing customer retention and satisfaction [6] - R&D expenses increased significantly in the first three quarters of 2025 due to intensified efforts in new product registration, aligning with industry trends [7] Production Capacity - The company has self-sufficient production capabilities for key plant growth regulator raw materials, with a project underway to produce 15,000 tons of raw materials and intermediates annually [7] M&A Strategy - The company aims for synergistic effects through acquisitions, focusing on targets in the plant growth regulator sector and those that enhance its comprehensive crop management solutions [8] Shareholder Returns - The company plans to actively and continuously return value to shareholders according to its three-year shareholder return plan for 2024-2026 [9] Business Cycle - The company's main business in plant growth regulators and high-end water-soluble fertilizers is less affected by macroeconomic factors, showing low demand elasticity and no significant cyclical characteristics [10]

| 驰、宝马、奥迪、大众、福特、通用、斯特兰提斯、保时捷等 | | --- | | 众多外知名海外客户建立起了合作关系。 | | Q3、公司固态电池目前进展？ | | 公司固态电池当前已经实现了连续化的试生产，并且在试 | | 生产过程中展现出较好的一致性。 | | Q4、公司固态电池性能上有何特点或优势？ | | 公司固态电池具有较高的安全性，通过了第三方检测机构 | | 的针刺、加热和过充电等安全试验，以及锂电池国际航运和陆 | | 运所需的 UN38.3 认证。 | | 公司固态电池另一个特点是具有较好的耐高温性能，依靠 | | 自然散热，即可在较高温度条件下连续正常工作。公司固态电 | | 池的耐高温特性，将为公司固态电池在狭小空间和场景下的应 | | 用提供更优的适配性。 | | Q5、公司固态电池在材料端与其他厂商的主要差别在哪？ | | 电解质材料体系的配方是公司固态电池技术的核心商业 | | 秘密，也是公司 2018 年投入固态电池研发以来不断摸索和迭 | | 代的成果。同时，公司掌握了固态电池材料体系的工艺窗口， | | 可以根据不同客户要求进行方案的定制化开发，以匹配不同应 | | 用场景 ...

| | ☑特定对象调研 □分析师会议 | | --- | --- | | | □媒体采访 业绩说明会 | | 投资者关系活动类别 | □新闻发布会 □路演活动 | | | □现场参观 | | | □其他 | | 活动参与人员 | 汇添富基金：刘高晓、高田昊等 | | | 申万宏源证券：邵靖宇、陈陶 | | 时间 | 2026 年 1 月 9 日 | | 地点 | 公司会议室 | | 形式 | 现场交流 | | 上市公司接待人员 | 董事会秘书 刘月刚 | | 姓名 | 证券事务代表 柳青 | | | 互动沟通主要内容如下： 一、介绍公司近期生产经营情况 | | | 近期园区整体生产经营情况正常，公司继续加强生产企业的冬季 安全管控，大力度开展节能降耗、提质增效，规避市场风险，紧跟相 | | | 关政策及行业发展动态，结合公司实际情况动态调整，统筹分析预判 | | | 市场变化，及时调整生产经营策略，发挥园区一体化优势，力争把握 | | 交流内容及具体问答 记录 | 市场机遇，实现经济效益最大化。 | | | 二、沟通了解 2025 年四季度产品市场变化情况 | | | 第四季度，受同行企业及下游企业开工率波 ...